Asparaginase is an essential element in the successful treatment of acute lymphoblastic leukaemia, the most common type of cancer affecting children, but AP is a side-effect occurring in about 5–10% of cases. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.